Skip to main content
Top
Published in: Clinical Research in Cardiology 9/2023

Open Access 08-05-2023 | CABG | Original Paper

Impact of repeat revascularization within 5 years on 10-year mortality after percutaneous or surgical revascularization

Authors: Rutao Wang, Mattia Lunardi, Hironori Hara, Chao Gao, Masafumi Ono, Piroze M. Davierwala, David R. Holmes, Friedrich W. Mohr, Nick Curzen, Francesco Burzotta, Robert-Jan van Geuns, Arie Pieter Kappetein, Stuart J. Head, Daniel J. F. M. Thuijs, Ling Tao, Scot Garg, Yoshinobu Onuma, William Wijns, Patrick W. Serruys

Published in: Clinical Research in Cardiology | Issue 9/2023

Login to get access

Abstract

Background

The SYNTAX trial demonstrated negative impact of repeat revascularization (RR) on 5-year outcomes following PCI/CABG in patients with three-vessel(3VD) and/or left main coronary artery disease(LMCAD). We aimed to investigate the impact of RR within 5 years, on 10-year mortality in patients with 3VD and/or LMCAD after PCI/CABG.

Methods

The SYNTAXES study evaluated the vital status out to 10 years of patients with 3VD and/or LMCAD. Patients were stratified by RR within 5 years and randomized treatment. The association between RR within 5 years and 10-year mortality was assessed.

Results

A total of 330 out of 1800 patients (18.3%) underwent RR within 5 years. RR occurred more frequently after initial PCI than after initial CABG (25.9% vs. 13.7%, p < 0.001). Overall, 10-year mortality was comparable between patients undergoing RR and those not (28.2% vs. 26.1%, adjusted HR: 1.17, 95%CI 0.93–1.48, p = 0.187). In the PCI arm, RR was associated with a trend toward higher 10-year mortality (adjusted HR: 1.29, 95%CI 0.97–1.72, p = 0.075), while in the CABG arm, the trend was opposite (adjusted HR: 0.74, 95%CI 0.46–1.20, p = 0.219). Among patients requiring RR, those who underwent PCI as initial revascularization had a higher risk of 10-year mortality compared to initial CABG (33.5% vs. 17.6%, adjusted HR: 2.09, 95%CI 1.21–3.61, p = 0.008).

Conclusion

In the SYNTAXES study, RR within 5 years had no impact on 10-year all-cause death in the population overall. Among patients requiring any repeat procedures, 10-year mortality was higher after initial treatment with PCI than after CABG. These exploratory findings should be investigated with larger populations in future studies.

Trial registration

URL: https://​www.​clinicaltrials.​gov; SYNTAXES Unique identifier: NCT03417050. URL: https://​www.​clinicaltrials.​gov; SYNTAX Unique identifier: NCT00114972.

Graphical abstract

Appendix
Available only for authorised users
Literature
1.
go back to reference Serruys PW, Ong AT, van Herwerden LA, Sousa JE, Jatene A, Bonnier JJ et al (2005) Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: the final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial. J Am Coll Cardiol 46(4):575–581CrossRefPubMed Serruys PW, Ong AT, van Herwerden LA, Sousa JE, Jatene A, Bonnier JJ et al (2005) Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: the final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial. J Am Coll Cardiol 46(4):575–581CrossRefPubMed
2.
go back to reference Rodriguez A, Bernardi V, Navia J, Baldi J, Grinfeld L, Martinez J et al (2001) Argentine randomized study: coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple-vessel disease (ERACI II): 30-day and one-year follow-up results. ERACI II Investigators. J Am Coll Cardiol 37(1):51–58CrossRefPubMed Rodriguez A, Bernardi V, Navia J, Baldi J, Grinfeld L, Martinez J et al (2001) Argentine randomized study: coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple-vessel disease (ERACI II): 30-day and one-year follow-up results. ERACI II Investigators. J Am Coll Cardiol 37(1):51–58CrossRefPubMed
3.
go back to reference Hueb W, Soares PR, Gersh BJ, César LA, Luz PL, Puig LB et al (2004) The medicine, angioplasty, or surgery study (MASS-II): a randomized, controlled clinical trial of three therapeutic strategies for multivessel coronary artery disease: one-year results. J Am Coll Cardiol 43(10):1743–1751CrossRefPubMed Hueb W, Soares PR, Gersh BJ, César LA, Luz PL, Puig LB et al (2004) The medicine, angioplasty, or surgery study (MASS-II): a randomized, controlled clinical trial of three therapeutic strategies for multivessel coronary artery disease: one-year results. J Am Coll Cardiol 43(10):1743–1751CrossRefPubMed
4.
go back to reference Babapulle MN, Joseph L, Belisle P, Brophy JM, Eisenberg MJ (2004) A hierarchical Bayesian meta-analysis of randomised clinical trials of drug-eluting stents. Lancet 364(9434):583–591CrossRefPubMed Babapulle MN, Joseph L, Belisle P, Brophy JM, Eisenberg MJ (2004) A hierarchical Bayesian meta-analysis of randomised clinical trials of drug-eluting stents. Lancet 364(9434):583–591CrossRefPubMed
5.
go back to reference Serruys PW, Morice MC, Kappetein AP, Colombo A, Holmes DR, Mack MJ et al (2009) Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med 360(10):961–972CrossRefPubMed Serruys PW, Morice MC, Kappetein AP, Colombo A, Holmes DR, Mack MJ et al (2009) Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med 360(10):961–972CrossRefPubMed
6.
go back to reference Thiele H, Neumann-Schniedewind P, Jacobs S, Boudriot E, Walther T, Mohr FW et al (2009) Randomized comparison of minimally invasive direct coronary artery bypass surgery versus sirolimus-eluting stenting in isolated proximal left anterior descending coronary artery stenosis. J Am Coll Cardiol 53(25):2324–2331CrossRefPubMed Thiele H, Neumann-Schniedewind P, Jacobs S, Boudriot E, Walther T, Mohr FW et al (2009) Randomized comparison of minimally invasive direct coronary artery bypass surgery versus sirolimus-eluting stenting in isolated proximal left anterior descending coronary artery stenosis. J Am Coll Cardiol 53(25):2324–2331CrossRefPubMed
7.
go back to reference Park SJ, Kim YH, Park DW, Yun SC, Ahn JM, Song HG et al (2011) Randomized trial of stents versus bypass surgery for left main coronary artery disease. N Engl J Med 364(18):1718–1727CrossRefPubMed Park SJ, Kim YH, Park DW, Yun SC, Ahn JM, Song HG et al (2011) Randomized trial of stents versus bypass surgery for left main coronary artery disease. N Engl J Med 364(18):1718–1727CrossRefPubMed
8.
go back to reference Taniwaki M, Stefanini GG, Silber S, Richardt G, Vranckx P, Serruys PW et al (2014) 4-Year clinical outcomes and predictors of repeat revascularization in patients treated with new-generation drug-eluting stents: a report from the RESOLUTE All-Comers trial (A Randomized Comparison of a Zotarolimus-Eluting Stent With an Everolimus-Eluting Stent for Percutaneous Coronary Intervention). J Am Coll Cardiol 63(16):1617–1625CrossRefPubMed Taniwaki M, Stefanini GG, Silber S, Richardt G, Vranckx P, Serruys PW et al (2014) 4-Year clinical outcomes and predictors of repeat revascularization in patients treated with new-generation drug-eluting stents: a report from the RESOLUTE All-Comers trial (A Randomized Comparison of a Zotarolimus-Eluting Stent With an Everolimus-Eluting Stent for Percutaneous Coronary Intervention). J Am Coll Cardiol 63(16):1617–1625CrossRefPubMed
9.
go back to reference Lamelas P, Belardi J, Whitlock R, Stone GW (2019) Limitations of repeat revascularization as an outcome measure: JACC review topic of the week. J Am Coll Cardiol 74(25):3164–3173CrossRefPubMed Lamelas P, Belardi J, Whitlock R, Stone GW (2019) Limitations of repeat revascularization as an outcome measure: JACC review topic of the week. J Am Coll Cardiol 74(25):3164–3173CrossRefPubMed
10.
go back to reference Parasca CA, Head SJ, Milojevic M, Mack MJ, Serruys PW, Morice MC et al (2016) Incidence, characteristics, predictors, and outcomes of repeat revascularization after percutaneous coronary intervention and coronary artery bypass grafting: the SYNTAX Trial at 5 years. JACC Cardiovasc Interv 9(24):2493–2507CrossRefPubMed Parasca CA, Head SJ, Milojevic M, Mack MJ, Serruys PW, Morice MC et al (2016) Incidence, characteristics, predictors, and outcomes of repeat revascularization after percutaneous coronary intervention and coronary artery bypass grafting: the SYNTAX Trial at 5 years. JACC Cardiovasc Interv 9(24):2493–2507CrossRefPubMed
11.
go back to reference Giustino G, Serruys PW, Sabik JF, Mehran R, Maehara A, Puskas JD et al (2020) Mortality after repeat revascularization following PCI or CABG for left main disease: the EXCEL trial. JACC Cardiovasc Interv 13(3):375–387CrossRefPubMed Giustino G, Serruys PW, Sabik JF, Mehran R, Maehara A, Puskas JD et al (2020) Mortality after repeat revascularization following PCI or CABG for left main disease: the EXCEL trial. JACC Cardiovasc Interv 13(3):375–387CrossRefPubMed
12.
go back to reference Ong AT, Serruys PW, Mohr FW, Morice MC, Kappetein AP, Holmes DR Jr et al (2006) The SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery (SYNTAX) study: design, rationale, and run-in phase. Am Heart J 151(6):1194–1204CrossRefPubMed Ong AT, Serruys PW, Mohr FW, Morice MC, Kappetein AP, Holmes DR Jr et al (2006) The SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery (SYNTAX) study: design, rationale, and run-in phase. Am Heart J 151(6):1194–1204CrossRefPubMed
13.
go back to reference Mohr FW, Morice MC, Kappetein AP, Feldman TE, Ståhle E, Colombo A et al (2013) Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial. Lancet (London, England) 381(9867):629–638CrossRefPubMed Mohr FW, Morice MC, Kappetein AP, Feldman TE, Ståhle E, Colombo A et al (2013) Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial. Lancet (London, England) 381(9867):629–638CrossRefPubMed
14.
go back to reference Thuijs D, Kappetein AP, Serruys PW, Mohr FW, Morice MC, Mack MJ et al (2019) Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial. Lancet 394:1325–1334CrossRefPubMed Thuijs D, Kappetein AP, Serruys PW, Mohr FW, Morice MC, Mack MJ et al (2019) Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial. Lancet 394:1325–1334CrossRefPubMed
15.
go back to reference Pocock SJ, McMurray JJV, Collier TJ (2015) Statistical controversies in reporting of clinical trials: part 2 of a 4-part series on statistics for clinical trials. J Am Coll Cardiol 66(23):2648–2662CrossRefPubMed Pocock SJ, McMurray JJV, Collier TJ (2015) Statistical controversies in reporting of clinical trials: part 2 of a 4-part series on statistics for clinical trials. J Am Coll Cardiol 66(23):2648–2662CrossRefPubMed
17.
go back to reference Genichi S, Takeshi S, Tatsuhiko K (2011) Impact of repeated percutaneous coronary intervention on long-term survival after subsequent coronary artery bypass surgery. J Cardiothorac Surg 6:107CrossRef Genichi S, Takeshi S, Tatsuhiko K (2011) Impact of repeated percutaneous coronary intervention on long-term survival after subsequent coronary artery bypass surgery. J Cardiothorac Surg 6:107CrossRef
18.
go back to reference Palmerini T, Della Riva D, Biondi-Zoccai G, Leon MB, Serruys PW, Smits PC et al (2018) Mortality following nonemergent, uncomplicated target lesion revascularization after percutaneous coronary intervention: an individual patient data pooled analysis of 21 randomized trials and 32,524 patients. JACC Cardiovasc Interv 11(9):892–902CrossRefPubMed Palmerini T, Della Riva D, Biondi-Zoccai G, Leon MB, Serruys PW, Smits PC et al (2018) Mortality following nonemergent, uncomplicated target lesion revascularization after percutaneous coronary intervention: an individual patient data pooled analysis of 21 randomized trials and 32,524 patients. JACC Cardiovasc Interv 11(9):892–902CrossRefPubMed
19.
go back to reference Wiebe J, Kuna C, Ibrahim T, Losl M, Cassese S, Kufner S et al (2020) Long-term prognostic impact of restenosis of the unprotected left main coronary artery requiring repeat revascularization. JACC Cardiovasc Interv 13(19):2266–2274CrossRefPubMed Wiebe J, Kuna C, Ibrahim T, Losl M, Cassese S, Kufner S et al (2020) Long-term prognostic impact of restenosis of the unprotected left main coronary artery requiring repeat revascularization. JACC Cardiovasc Interv 13(19):2266–2274CrossRefPubMed
20.
go back to reference Askin L, Tanriverdi O (2022) The clinical value of syntax scores in predicting coronary artery disease outcomes. Cardiovasc Innov Appl 6(4):197–208 Askin L, Tanriverdi O (2022) The clinical value of syntax scores in predicting coronary artery disease outcomes. Cardiovasc Innov Appl 6(4):197–208
21.
go back to reference Kim JW, Suh SY, Choi CU, Na JO, Kim EJ, Rha SW et al (2008) Six-month comparison of coronary endothelial dysfunction associated with sirolimus-eluting stent versus Paclitaxel-eluting stent. JACC Cardiovasc Interv 1(1):65–71CrossRefPubMed Kim JW, Suh SY, Choi CU, Na JO, Kim EJ, Rha SW et al (2008) Six-month comparison of coronary endothelial dysfunction associated with sirolimus-eluting stent versus Paclitaxel-eluting stent. JACC Cardiovasc Interv 1(1):65–71CrossRefPubMed
22.
go back to reference Hamilos M, Sarma J, Ostojic M, Cuisset T, Sarno G, Melikian N et al (2008) Interference of drug-eluting stents with endothelium-dependent coronary vasomotion: evidence for device-specific responses. Circ Cardiovasc Interv 1(3):193–200CrossRefPubMed Hamilos M, Sarma J, Ostojic M, Cuisset T, Sarno G, Melikian N et al (2008) Interference of drug-eluting stents with endothelium-dependent coronary vasomotion: evidence for device-specific responses. Circ Cardiovasc Interv 1(3):193–200CrossRefPubMed
23.
go back to reference Taggart DP (2013) CABG or stents in coronary artery disease: end of the debate? Lancet (London, England) 381(9867):605–607CrossRefPubMed Taggart DP (2013) CABG or stents in coronary artery disease: end of the debate? Lancet (London, England) 381(9867):605–607CrossRefPubMed
25.
go back to reference Chikwe J, Sun E, Hannan EL, Itagaki S, Lee T, Adams DH et al (2019) Outcomes of second arterial conduits in patients undergoing multivessel coronary artery bypass graft surgery. J Am Coll Cardiol 74(18):2238–2248CrossRefPubMed Chikwe J, Sun E, Hannan EL, Itagaki S, Lee T, Adams DH et al (2019) Outcomes of second arterial conduits in patients undergoing multivessel coronary artery bypass graft surgery. J Am Coll Cardiol 74(18):2238–2248CrossRefPubMed
26.
go back to reference Locker C, Greiten LE, Bell MR, Frye RL, Lerman A, Daly RC et al (2019) Repeat coronary bypass surgery or percutaneous coronary intervention after previous surgical revascularization. Mayo Clin Proc 94(9):1743–1752CrossRefPubMed Locker C, Greiten LE, Bell MR, Frye RL, Lerman A, Daly RC et al (2019) Repeat coronary bypass surgery or percutaneous coronary intervention after previous surgical revascularization. Mayo Clin Proc 94(9):1743–1752CrossRefPubMed
27.
go back to reference Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U et al (2019) 2018 ESC/EACTS guidelines on myocardial revascularization. Eur Heart J 40(2):87–165CrossRefPubMed Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U et al (2019) 2018 ESC/EACTS guidelines on myocardial revascularization. Eur Heart J 40(2):87–165CrossRefPubMed
28.
go back to reference Lawton JS, Tamis-Holland JE, Bangalore S, Bates ER, Beckie TM, Bischoff JM et al (2021) ACC/AHA/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 2021:CIR0000000000001038 Lawton JS, Tamis-Holland JE, Bangalore S, Bates ER, Beckie TM, Bischoff JM et al (2021) ACC/AHA/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 2021:CIR0000000000001038
29.
go back to reference Lauer MSBE, Young JB, Topol EJ (1999) Cause of death in clinical research: time for a reassessment? J Am Coll Cardiol 34:618–620CrossRefPubMed Lauer MSBE, Young JB, Topol EJ (1999) Cause of death in clinical research: time for a reassessment? J Am Coll Cardiol 34:618–620CrossRefPubMed
Metadata
Title
Impact of repeat revascularization within 5 years on 10-year mortality after percutaneous or surgical revascularization
Authors
Rutao Wang
Mattia Lunardi
Hironori Hara
Chao Gao
Masafumi Ono
Piroze M. Davierwala
David R. Holmes
Friedrich W. Mohr
Nick Curzen
Francesco Burzotta
Robert-Jan van Geuns
Arie Pieter Kappetein
Stuart J. Head
Daniel J. F. M. Thuijs
Ling Tao
Scot Garg
Yoshinobu Onuma
William Wijns
Patrick W. Serruys
Publication date
08-05-2023
Publisher
Springer Berlin Heidelberg
Keywords
CABG
CABG
Published in
Clinical Research in Cardiology / Issue 9/2023
Print ISSN: 1861-0684
Electronic ISSN: 1861-0692
DOI
https://doi.org/10.1007/s00392-023-02211-6

Other articles of this Issue 9/2023

Clinical Research in Cardiology 9/2023 Go to the issue